Abstract:Helicobacter pylori (H. pylori), as a harmful bacteria associated with gastric cancer, can have adverse effects on human normal flora and metabolism. However, the effects of H. pylori on human metabolism have not been fully elucidated. The 13 C breathing test was used as the basis for distinguishing negative and positive groups. Serum samples were collected from the two groups for targeted quantitative metabolomics detection; multidimensional statistics were used, including partial least squares discriminant analysis (PLS-DA), principal component analysis (PCA), orthogonal partial least squares discriminant analysis (OPLS-DA), and differential metabolites were screened. Unidimensional statistics combined with multidimensional statistics were used to further screen potential biomarkers, and finally pathway analysis was performed. SPSS 21.0 software package was used for statistical analysis of experimental data. Multivariate statistical analysis such as PLS-DA, PCA, and OPLS-DA was performed using Simca-P 13.0 to search for differential metabolites. This study confirmed that H. pylori caused significant changes in human metabolism. In this experiment, 211 metabolites were detected in the serum of the two groups. Multivariate statistical analysis showed that PCA of metabolites was not significantly different between the two groups. PLS-DA indicated that the serum of the two groups was well clustered. There were significant differences in metabolites between OPLS-DA groups. By setting the variable importance in projection (VIP) threshold as one and the corresponding P-value <0.05, a total of 40 metabolites were screened in this study. P <0.05 and ∣log2FC∣>0 (where FC is the fold change) were used together as a unidimensional statistical filter condition. The analysis found that the expression of 15 metabolites such as propionic acid, acetic acid, adipic acid increased, and the metabolism of six products such as deoxycholic acid (DCA), 4-hydroxyphenylpyruvic acid, pyruvic acid decreased. P <0.05, false discovery rate <0.5, ∣log2FC∣>1, and OPLSDA_VIP>1 were used together as a condition for filter screening potential biomarkers. Four potential biomarkers were screened, which were sebacic acid, isovaleric acid, DCA, and indole-3-carboxylic acid. Finally, the different metabolites were added to the pathway-associated metabolite sets (SMPDB) library for the corresponding pathway enrichment analysis. The significant abnormal metabolic pathways were taurine and subtaurine metabolism, tyrosine metabolism, glycolysis or gluconeogenesis, pyruvate metabolism, etc. This study shows that H. pylori has an impact on human metabolism. Not only a variety of metabolites have significant changes, but also metabolic pathways are abnormal, which may be the reason for the high risk of H. pylori causing gastric cancer.

Metabolic alterations in patients with Helicobacter pylori‐related gastritis: The H. pylori‐gut microbiota‐metabolism axis in progression of the chronic inflammation in the gastric mucosa

Role of the Gastric Microbiome in Gastric Cancer: from Carcinogenesis to Treatment

Targeted metabolomics analysis for serum Helicobacter pylori-positive based on liquid chromatography-tandem mass spectrometry

Interactions between Helicobacter pylori infection and host metabolic homeostasis: A comprehensive review

Alterations of Gastric Mucosal Microbiota Across Different Stomach Microhabitats in a Cohort of 276 Patients with Gastric Cancer

Influence of helicobacter pylori on composition and function of gastric microbiota in patients with chronic non-atrophic gastritis

The Impact of Helicobacter Pylori Infection, Eradication Therapy and Probiotic Supplementation on Gut Microenvironment Homeostasis: an Open-Label, Randomized Clinical Trial

Urinary metabolic profiles during Helicobacter pylori eradication in chronic gastritis

Metabolite Alterations and Interactions with Microbiota in Helicobacter pylori-Associated Gastric Lesions

Interactions between gastric microbiota and metabolites in gastric cancer

Effect of <i>Helicobacter pylori</i> on gastrointestinal microbiota: a population-based study in Linqu, a high-risk area of gastric cancer

Characterization of the Gastric Mucosal Microbiota in Patients with Liver Cirrhosis and Its Associations with Gastrointestinal Symptoms

Effect of Helicobacter Pylori on Plasma Metabolic Phenotype in Patients With Gastric Cancer

Helicobacter pylori causes gastric dysbacteriosis in chronic gastritis patients

Gut Microbiota: The Missing Link Between Helicobacter pylori Infection and Metabolic Disorders?

Helicobacter pylori infection affects the human gastric microbiome, as revealed by metagenomic sequencing

Alterations in the Human Gut Microbiome Associated with Helicobacter Pylori Infection

Association Between Gut Microbiota and Helicobacter Pylori-Related Gastric Lesions in a High-Risk Population of Gastric Cancer.

Effects of Helicobacter Pylori Eradication on the Profiles of Blood Metabolites and Their Associations with the Progression of Gastric Lesions: a Prospective Follow-Up Study

Alterations in mucosa-associated microbiota in the stomach of patients with gastric cancer

Association of miR-499 rs3746444, miR-149 rs2292832 polymorphisms and their expression levels with helicobacter pylori-related gastric diseases and Traditional Chinese Medicine syndromes